Document 0590 DOCN M94A0590 TI Relapsing Helicobacter cinaedi bacteremia in an AIDS patient. DT 9412 AU Munckhof WJ; Street AC; Tee W; Fairfield Hospital, Vic. SO Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:91 (poster no. 33). Unique Identifier : AIDSLINE ASHM5/94349065 AB Helicobacter cinaedi is a rare cause of gastroenteritis and bacteremia occurring most commonly in immunocompromised patients. We report a case of Helicobacter cinaedi bacteremia in an AIDS patient that relapsed despite a course of adequate antibiotic treatment. A 33 year old patient with AIDS diagnosed 1 year previously was being treated with zidovudine when a large cell lymphoma of the larynx was diagnosed. His CD4 cell count was less than 50/microliters. Chemotherapy was commenced and he developed febrile neutropenia and mild diarrhoea an was treated with ceftazidime. Faecal Clostridium difficile toxin assay was positive and oral vancomycin was added. Blood cultures became positive on day 3 of incubation (Bactec system), and curved Gram negative rods were seen on smear. The organism was further identified as Helicobacter cinaedi. Antibiotic sensitivity testing was difficult, but apparent sensitivity was demonstrated to erythromycin, gentamicin and ciprofloxacin. Faecal cultures were negative. Gentamicin was started, and fever settled. He was treated for 9 days with IV gentamicin, and a further 10 days with oral ciprofloxacin, after which blood cultures were negative. A month later, he was readmitted with septic shock and died within a day. Blood cultures grew Staph aureus and Helicobacter cinaedi. DE Adult Antibiotics, Combined/THERAPEUTIC USE AIDS-Related Opportunistic Infections/*DIAGNOSIS/DRUG THERAPY/ MICROBIOLOGY Bacteremia/*DIAGNOSIS/DRUG THERAPY/MICROBIOLOGY Case Report Ciprofloxacin/ADMINISTRATION & DOSAGE Fatal Outcome Gentamicins/ADMINISTRATION & DOSAGE Helicobacter/CLASSIFICATION/DRUG EFFECTS Helicobacter Infections/*DIAGNOSIS/DRUG THERAPY/MICROBIOLOGY Human Male MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).